Highlights Galderma Group AG

Stocks

GALD

CH1335392721

Personal Products

Market Closed - Swiss Exchange Other stock markets 09:00:32 10/07/2026 pm IST			5-day change	1st Jan Change
172.85 ^CHF	-0.89%		-3.73%	+6.63%

09/07	RBC Expects Slowdown in Galderma's Q2 Sales Growth; Price Target, Estimates Revised	MT
08/07	Swiss Market Index Slips Back into Red; Barry Callebaut Shares Down	MT

Highlights

09/07	RBC Expects Slowdown in Galderma's Q2 Sales Growth; Price Target, Estimates Revised	MT
03/07	Galderma Group Forecasts Revised as BofA Notes US FDA Response to Relfydess Application	MT
02/07	Health Care Up on AI Rotation - Health Care Roundup	DJ
01/07	US FDA Responds to Galderma's Bologics License Application for Liquid Neuromodulator	MT
01/07	Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States	CI
08/06	Berenberg Names Galderma as a 'Preferred' Swiss Stock Amid 'Unparalleled' Midterm Growth Potential	MT
29/05	Berenberg Upgrades L'Oréal Rating, Price Target Amid Beauty Market Turnaround	MT
25/05	Galderma Obtains US FDA Nod for Over-the-counter Sale of Acne Gel	MT
22/05	Galderma receives U.S. FDA approval for Differin Epiduo acne gel prescription-to-OTC switch	RE
22/05	Galderma Receives Fda Approval for Differin Epiduo Acne Gel Prescription-To-Otc Switch	CI
11/05	Galderma Group's Maiden Capital Markets Day to Target Funds Allocation, Berenberg Says	MT
30/04	Galderma Benefits From a Positive Jefferies Rating
27/04	Galderma One of Berenberg's 2026 Top Picks Amid 'Strong Set' of Q1 Results	MT
23/04	Galderma Shares Gain After Sales Increase, Confidence on Outlook	DJ
23/04	Skincare company Galderma posts 25.5% sales leap, driven by US market	RE
23/04	Galderma's Q1 Net Sales Rise; FY26 Outlook Affirmed	MT
23/04	Galderma Q1 net sales of $1.473 billion, up 25.5%	RE
22/04	Galderma Group AG Approves Payment of Dividend, Payable on April 28, 2026	CI
17/04	RBC Keeps Galderma at Sector Perform Rating Ahead of Q1 Results, Says Growth Momentum Already Priced In	MT
16/04	Galderma Group AG Launches Alastin Regenerating Skin Nectar with Trihex+	CI
09/04	Galderma Reports Interim Data from Investigator-Initiated Trials on Sculptra and Restylane for Aesthetic Changes in Weight Loss and Menopause	CI
08/04	Galderma Launches ALASTIN Signature Practices	CI
01/04	Galderma Price Target Up as Berenberg Notes 'Increased Confidence' in Growth Potential	MT
01/04	BofA Forecasts Galderma Q1 Sales Growth on Nemluvio Launch Benefits, Injectable Aesthetics Boost	MT
28/03	Galderma Announces Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 with Moderate-To-Severe Atopic Dermatitis	CI